GSK3β Inhibitors Inhibit TGFβ Signaling in the Human Trabecular Meshwork
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.10.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Chenna Kesavulu Sugali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States. Hauptthemen laut MEDLINE: Trabecular Meshwork, Intraocular Pressure, Glaucoma, Open-Angle, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Purpose
Primary open-angle glaucoma (POAG) is a leading cause of blindness, and its primary risk factor is elevated intraocular pressure (IOP) due to pathologic changes in the trabecular meshwork (TM). We previously showed that there is a cross-inhibition between TGFβ and Wnt signaling pathways in the TM. In this study, we determined if activation of the Wnt signaling pathway using small-molecule Wnt activators can inhibit TGFβ2-induced TM changes and ocular hypertension (OHT).
Methods
Primary human TM (pHTM) cells and transduced SBE-GTM3 cells were treated with or without Wnt and/or TGFβ signaling activators and used for luciferase assays; for the extraction of whole-cell lysate, conditioned medium, cytosolic proteins, and nuclear proteins for Western immunoblotting (WB); or for immunofluorescent staining. Human donor eyes were perfusion cultured to study the effect of Wnt activators on IOP.
Results
We found that the small-molecule Wnt activators (GSK3β inhibitors) (BIO, SB216763, and CHIR99021) activated canonical Wnt signaling in pHTM cells without toxicity at tested concentrations. This activation inhibited TGFβ signaling as well as TGFβ2-induced extracellular matrix deposition and formation of cross-linked actin networks in pHTM cells or SBE-GTM3 cells. We also observed nuclear translocation of both Smad4 and β-catenin in pHTM cells, which suggested that the cross-inhibition between the TGFβ and Wnt signaling pathways may occur in the nucleus. Using our ex vivo model, we found that CHIR99021 inhibited TGFβ2-induced OHT in perfusion-cultured human eyes.
Conclusions
Our results showed that small-molecule Wnt activators have the potential for treating TGFβ signaling-induced OHT in patients with POAG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States.
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States.
- Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States.
- STARK Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Förderung
- NEI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Sugali, C. K., Rayana, N. P., Dai, J., Harvey, D. H., Dhamodaran, K., & Mao, W. (2024). GSK3β Inhibitors Inhibit TGFβ Signaling in the Human Trabecular Meshwork. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.10.3
Vancouver
Sugali CK, Rayana NP, Dai J, Harvey DH, Dhamodaran K, Mao W. GSK3β Inhibitors Inhibit TGFβ Signaling in the Human Trabecular Meshwork. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.10.3
BibTeX
@article{Sugali2024,
author = {Sugali, Chenna Kesavulu and Rayana, Naga Pradeep and Dai, Jiannong and Harvey, Devon H and Dhamodaran, Kamesh and Mao, Weiming},
title = {GSK3β Inhibitors Inhibit TGFβ Signaling in the Human Trabecular Meshwork},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.10.3}
}
EUVIMED